Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure

Clinical trial NCT04311697 · COMPLETED

Trial details

NCT number: NCT04311697
Sponsor: APR Applied Pharma Research s.a.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Critical COVID-19 With Respiratory Failure Acute Respiratory Distress Syndrome (ARDS)Corona Virus Infection Acute Lung Injury

Start date: 2020-05-15
Primary completion: 2021-02-22
Enrollment: 203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.